Duke Structural Heart Disease Symposium 2025
This is a Duke Heart Symposium focused on structural heart disease (SHD). The overall goal of the activity is to enhance learners’ knowledge and improve their competency in the evaluation and treatment of patients with a valvular and congenital heart disease.
Target Audience
Allied Health Professionals
Fellows
Nurses
Nurse Practitioners
Physicians
Physician Assistants
Residents
Learning Objectives
Explaining treatment options available to patients with valvular and structural heart disease, including investigational treatment options
Discussing clinical risk assessment and use of online surgical risk calculators for quantifying risk
Discussing the treatment advantages of specific treatment options for various structural heart diseases
Defining the clinical changes being implemented based on the recent randomized clinical trials
J. Kevin Harrison, MD
Andres Pineda Maldonado
Thaer Musa, MD
Lynne Koweek, MD
Louis Dibernardo, MD
Adam Williams, MD
Sreekanth Vemulapalli, MD
Andrew Wang, MD
G. Chad Hughes, MD
Edana Christy, NP
Fawaz Alenezi, MD
Chelsea Tinlin, RN
Zachary Wegermann, MD
Brittany Zwischenberger, MD
Ezequiel Munoz, MD
Angela Lowenstern
Adam Banks
Sharif Halim
AMA PRA Category 1 Credit(s)
Attendance
JA Credit- AH
ANCC
Available Credit
- 6.50 AMA PRA Category 1 Credit(s)™
- 6.50 ANCC
- 6.50 Attendance
- 6.50 JA Credit - AH
- 6.50 Approved for AMA PRA Category 1 Credit(s)™